Search

Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference
Matt Biegler summarizes a breast cancer panel from the conference and talks about recent data from Relay and upcoming data from Gilead....
Sep 26, 2024

Houston Oncology Summit: Oppenheimer analyst Matthew Biegler talks about synthetic lethality
He describes how PARP inhibitors were initial successes and where the field is going now beyond PARP with new targets.
Sep 21, 2023